EHS tumor–derived BMEs contain heterogenous mixtures of extracellular matrix proteins, primarily laminins, collagen IV, entactin, and perlecan as well as tumor-derived proteins and growth factors, which contribute to batch-to-batch variability (18, 19). The gene discussed is NID1; the disease is neoplasm.